文献速递睡眠呼吸障碍

自动调节与固定压力CPAP治疗阻塞性睡眠呼吸暂停:多中心随机等效性试验

Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial.
PubMed 文献 · Thorax · 2017-10-05

这项多中心随机等效性试验纳入208例OSAS患者,比较自动调节CPAP(5-15 mbar)与固定CPAP在改善嗜睡方面的长期效果。2年时两组ESS降幅和睡眠抵抗时间增加相似,差异的95%CI均在预设等效范围内,血压下降和OSAS相关费用也相似。

要点

  • 自动CPAP与固定CPAP在改善主观和客观嗜睡方面2年内等效。
  • 两组ESS变化差异95%CI为-0.9至+1.4,睡眠抵抗时间差异95%CI为-2.6至+1.0 min。
  • 两组血压下降和OSAS相关费用相似。

核心结论

  • 在预设等效范围内,自动CPAP与固定CPAP在2年内改善OSAS患者主观和客观嗜睡方面等效。
  • 两种治疗的费用相似。

研究设计与样本

  • 多中心随机等效性试验,208例OSAS患者随机接受自动CPAP(5-15 mbar)或固定CPAP治疗。
  • 固定CPAP压力设定为自动CPAP在2-4周适应期内所应用的90百分位压力。
  • 共同主要结局为基线至治疗2年时主观和客观嗜睡的变化。
  • 等效范围为ESS ±2分和睡眠抵抗时间 ±3 min。

主要发现

  • 2年时意向性分析中,自动CPAP组(n=113)ESS平均变化-6.3(95%CI -7.1至-5.5),睡眠抵抗时间+8.3 min(95%CI +6.9至+9.7)。
  • 固定CPAP组(n=95)ESS平均变化-6.2(95%CI -7.0至-5.3),睡眠抵抗时间+6.3 min(95%CI +4.7至+7.8)。
  • 自动CPAP与固定CPAP之间ESS降幅差异的95%CI为-0.9至+1.4。
  • 睡眠抵抗时间增加差异的95%CI为-2.6至+1.0 min。
  • 两组血压下降和OSAS相关费用相似。

关键数值与推荐

  • 等效范围:ESS ±2分,睡眠抵抗时间 ±3 min。
  • 自动CPAP压力范围5-15 mbar;固定CPAP压力设定为自动CPAP适应期90百分位压力。
  • 主要结局评估时间点为治疗2年。

临床怎么用

  • 对于OSAS患者,自动CPAP和固定CPAP均可作为改善长期嗜睡的有效治疗选择。
  • 两种治疗费用相似,选择时可结合患者偏好和设备可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The obstructive sleep apnoea syndrome (OSAS) is conventionally treated by continuous positive airway pressure set at a fixed level (fCPAP). Automatic mask pressure adjustment (autoCPAP) is increasingly used during home therapy. We investigated whether autoCPAP is equivalent to fCPAP in improving sleepiness in patients with OSAS in the long-term. METHODS: In this multicentre equivalence trial, 208 patients with OSAS, with median Epworth sleepiness score (ESS) 13, apnoea/hypopnoea index 48.4/hour, were randomised to treatment with autoCPAP (5-15 mbar) or fCPAP (pressure set at the 90th percentile applied by autoCPAP during 2-4 weeks adaptation). Coprimary outcomes were changes in subjective and objective sleepiness from baseline to 2 years after treatment. Equivalence ranges were ±2 points in ESS and ±3 min sleep resistance time evaluated by recording responses to light signals. RESULTS: At 2 years, in the intention to treat analysis, the reduction in sleepiness versus pretreatment baseline was similar in patients using autoCPAP (n=113, mean ESS-change -6.3, 95% CI -7.1 to -5.5; sleep resistance time +8.3 min, +6.9 to +9.7) and fCPAP (n=95, mean ESS-change -6.2, 95% CI -7.0 to -5.3; sleep resistance time +6.3 min, +4.7 to +7.8). The 95% CI of difference in ESS-reduction between autoCPAP and fCPAP was -0.9 to +1.4 and the 95% CI of difference in increase in sleep resistance time was -2.6 to +1.0 min. Blood pressure reduction and OSAS-related costs were similar between groups. CONCLUSIONS: AutoCPAP and fCPAP are equivalent within prespecified ranges in improving subjective and objective sleepiness in patients with OSAS over the course of 2 years. Costs of these treatments are similar. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT00280800.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Bloch KE, Huber F, Furian M, et al. Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial. Thorax. 2017. PMID: 28982804. doi:10.1136/thoraxjnl-2016-209699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。